🇵🇱
Peptide Laws in Poland
PL · Europe · 23 peptides tracked
Grey AreaEnforcement: Lenient
Are Peptides Legal in Poland?
Poland operates under the EU framework through URPL, but is notably more permissive for research peptides than Western Europe. Enforcement against individual buyers is minimal, and several peptide vendors serve the Polish and broader Eastern European market. The regulatory focus is on large-scale commercial operations. Semaglutide is available by prescription. One of the more accessible EU countries for research peptides.
4
Legal16
Grey Area3
PrescriptionCan You Buy Peptides in Poland?
4 peptide(s) are legal to buy in Poland, including GHK-Cu, NAD+, Glutathione, Vitamin B12. 3 peptide(s) require a valid prescription, including Tirzepatide, Semaglutide, CJC-1295. 16 peptide(s) fall into a legal grey area: Retatrutide, Selank, MOTS-c, TB-500, AOD-9604, and 11 more. These may be available for research purposes but their legality for personal use is ambiguous.
Traveling to Poland with Peptides
When traveling to Poland with peptides, the legality depends on each peptide's classification. Prescription peptides (Tirzepatide, Semaglutide, CJC-1295) typically require documentation such as a prescription or doctor's letter when crossing borders. Enforcement in Poland is rated as "Lenient." Always declare pharmaceutical products at customs and carry documentation of any prescriptions.
New to peptides? Start with the basics on peptide.camp →
Need to source peptides for Poland? Get verified wholesale quotes on peptide.broker →
Traveling to Poland with peptides? TSA tips, packing guides & the peptide travel case on peptide.travel →
Peptide Regulations in Poland
| Peptide | Status | Rx Required | Schedule | Detail | Source |
|---|---|---|---|---|---|
| Retatrutide | Grey Area | No | Investigational | Phase 3 clinical trials. No EMA approval. Any online sales illegal. FDA warned against compounded versions. Poland has no simple-possession offence, but the Ustawa o zwalczaniu dopingu w sporcie (Dz.U. 2017 poz. 1051) art. 49(1) criminalises making WADA group S1/S2/S4 substances available to third parties whether or not for payment, or holding them for that purpose, and art. 49(3) makes importing them contrary to Prawo farmaceutyczne art. 68 a standalone offence. Penalties: fine, restriction of liberty, or up to 3 years. Regulator: POLADA. | Official |
| Selank | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. Approved in Russia. Research-label available. Not on WADA prohibited list. Poland has no simple-possession offence, but the Ustawa o zwalczaniu dopingu w sporcie (Dz.U. 2017 poz. 1051) art. 49(1) criminalises making WADA group S1/S2/S4 substances available to third parties whether or not for payment, or holding them for that purpose, and art. 49(3) makes importing them contrary to Prawo farmaceutyczne art. 68 a standalone offence. Penalties: fine, restriction of liberty, or up to 3 years. Regulator: POLADA. | Official |
| Tirzepatide | Prescription | Yes | EMA Authorized (Rx) | EMA-authorized. Mounjaro. Prescription required. Poland has no simple-possession offence, but the Ustawa o zwalczaniu dopingu w sporcie (Dz.U. 2017 poz. 1051) art. 49(1) criminalises making WADA group S1/S2/S4 substances available to third parties whether or not for payment, or holding them for that purpose, and art. 49(3) makes importing them contrary to Prawo farmaceutyczne art. 68 a standalone offence. Penalties: fine, restriction of liberty, or up to 3 years. Regulator: POLADA. | Official |
| MOTS-c | Grey Area | No | Not Scheduled / Unauthorized | Research peptide. No EMA authorization. WADA banned. Minimal enforcement attention. Poland has no simple-possession offence, but the Ustawa o zwalczaniu dopingu w sporcie (Dz.U. 2017 poz. 1051) art. 49(1) criminalises making WADA group S1/S2/S4 substances available to third parties whether or not for payment, or holding them for that purpose, and art. 49(3) makes importing them contrary to Prawo farmaceutyczne art. 68 a standalone offence. Penalties: fine, restriction of liberty, or up to 3 years. Regulator: POLADA. | Official |
| TB-500 | Grey Area | No | Not Scheduled / Unauthorized | Same permissive environment. Poland is a source country for European peptide market. Poland has no simple-possession offence, but the Ustawa o zwalczaniu dopingu w sporcie (Dz.U. 2017 poz. 1051) art. 49(1) criminalises making WADA group S1/S2/S4 substances available to third parties whether or not for payment, or holding them for that purpose, and art. 49(3) makes importing them contrary to Prawo farmaceutyczne art. 68 a standalone offence. Penalties: fine, restriction of liberty, or up to 3 years. Regulator: POLADA. | Official |
| GHK-Cu | Legal | No | Cosmetic Ingredient | Legal cosmetic ingredient under EU Cosmetics Regulation 1223/2009. Topical forms sold freely. Injectable form unauthorized. Poland has no simple-possession offence, but the Ustawa o zwalczaniu dopingu w sporcie (Dz.U. 2017 poz. 1051) art. 49(1) criminalises making WADA group S1/S2/S4 substances available to third parties whether or not for payment, or holding them for that purpose, and art. 49(3) makes importing them contrary to Prawo farmaceutyczne art. 68 a standalone offence. Penalties: fine, restriction of liberty, or up to 3 years. Regulator: POLADA. | Official |
| AOD-9604 | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GH fragment. Research-label available. Poland has no simple-possession offence, but the Ustawa o zwalczaniu dopingu w sporcie (Dz.U. 2017 poz. 1051) art. 49(1) criminalises making WADA group S1/S2/S4 substances available to third parties whether or not for payment, or holding them for that purpose, and art. 49(3) makes importing them contrary to Prawo farmaceutyczne art. 68 a standalone offence. Penalties: fine, restriction of liberty, or up to 3 years. Regulator: POLADA. | Official |
| Semaglutide | Prescription | Yes | EMA Authorized (Rx) | EMA-authorized. Ozempic/Wegovy. Prescription required. Massive counterfeit/compounded market. EMA warned of 'sharp rise in illegal medicines'. Poland has no simple-possession offence, but the Ustawa o zwalczaniu dopingu w sporcie (Dz.U. 2017 poz. 1051) art. 49(1) criminalises making WADA group S1/S2/S4 substances available to third parties whether or not for payment, or holding them for that purpose, and art. 49(3) makes importing them contrary to Prawo farmaceutyczne art. 68 a standalone offence. Penalties: fine, restriction of liberty, or up to 3 years. Regulator: POLADA. | Official |
| CJC-1295 | Prescription | Yes | Unauthorized Medicine | No EMA authorization. GHRH analog. WADA banned. Research-label available. Poland has no simple-possession offence, but the Ustawa o zwalczaniu dopingu w sporcie (Dz.U. 2017 poz. 1051) art. 49(1) criminalises making WADA group S1/S2/S4 substances available to third parties whether or not for payment, or holding them for that purpose, and art. 49(3) makes importing them contrary to Prawo farmaceutyczne art. 68 a standalone offence. Penalties: fine, restriction of liberty, or up to 3 years. Regulator: POLADA. | Official |
| Semax | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. Approved in Russia. Research-label available. Not on WADA prohibited list. Poland has no simple-possession offence, but the Ustawa o zwalczaniu dopingu w sporcie (Dz.U. 2017 poz. 1051) art. 49(1) criminalises making WADA group S1/S2/S4 substances available to third parties whether or not for payment, or holding them for that purpose, and art. 49(3) makes importing them contrary to Prawo farmaceutyczne art. 68 a standalone offence. Penalties: fine, restriction of liberty, or up to 3 years. Regulator: POLADA. | Official |
| Ipamorelin | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRP. WADA banned. Research-label available. Poland has no simple-possession offence, but the Ustawa o zwalczaniu dopingu w sporcie (Dz.U. 2017 poz. 1051) art. 49(1) criminalises making WADA group S1/S2/S4 substances available to third parties whether or not for payment, or holding them for that purpose, and art. 49(3) makes importing them contrary to Prawo farmaceutyczne art. 68 a standalone offence. Penalties: fine, restriction of liberty, or up to 3 years. Regulator: POLADA. | Official |
| NAD+ | Legal | No | Supplement / Novel Food | Supplements (NMN/NR) widely sold. IV infusions at clinics. NMN awaiting EFSA novel food assessment (Uthever 2025). Poland has no simple-possession offence, but the Ustawa o zwalczaniu dopingu w sporcie (Dz.U. 2017 poz. 1051) art. 49(1) criminalises making WADA group S1/S2/S4 substances available to third parties whether or not for payment, or holding them for that purpose, and art. 49(3) makes importing them contrary to Prawo farmaceutyczne art. 68 a standalone offence. Penalties: fine, restriction of liberty, or up to 3 years. Regulator: POLADA. | Official |
| BPC-157 | Grey Area | No | Not Scheduled / Unauthorized | Major EU peptide distribution hub. Enforcement permissive. Research vendors operate widely. Poland has no simple-possession offence, but the Ustawa o zwalczaniu dopingu w sporcie (Dz.U. 2017 poz. 1051) art. 49(1) criminalises making WADA group S1/S2/S4 substances available to third parties whether or not for payment, or holding them for that purpose, and art. 49(3) makes importing them contrary to Prawo farmaceutyczne art. 68 a standalone offence. Penalties: fine, restriction of liberty, or up to 3 years. Regulator: POLADA. | Official |
| DSIP | Grey Area | No | Not Scheduled / Unauthorized | — | Unsourced |
| Epithalon | Grey Area | No | Not Scheduled / Unauthorized | — | Unsourced |
| Glutathione | Legal | No | Supplement | — | Unsourced |
| HGH | Grey Area | No | Unregistered | — | Unsourced |
| KPV | Grey Area | No | Not Scheduled / Unauthorized | — | Unsourced |
| Melanotan II | Grey Area | No | Not Scheduled / Unauthorized | — | Unsourced |
| Liraglutide | Grey Area | No | Unregistered | — | Unsourced |
| MK-677 | Grey Area | No | Unregistered | — | Unsourced |
| Vitamin B12 | Legal | No | Supplement | — | Unsourced |
| PT-141 | Grey Area | No | Unregistered | — | Unsourced |
About the sources on this page
Entries marked Official cite a government regulator, legislation or an official gazette. Some entries currently carry no source at all.
We show these entries rather than hiding them, but they should not be relied on. Nothing on this site is legal advice. Verify against the national regulator before acting, and if you can point us at a better source please submit an update.
Data is researcher-verified but not legal advice. Always consult local regulations before purchasing, importing, or traveling with peptides. Last verified: 2026-02-28.